Zimmer Biomet Holdings, Inc. (ZBH) News
Follow Zimmer Biomet Holdings, Inc. (ZBH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 33 public stories across 15 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Zimmer Biomet Raises Annual Adjusted Profit Forecast; Shares Hit Highest Since April 2025
EQUITY | Nov 04, 2026, 05:09 PM UTC
M
Zimmer Biomet Shares Rise After Raising Annual Adjusted Profit Outlook
Zimmer Biomet shares rose 3% in premarket trading after the medical-device maker raised its annual adjusted profit outlook.
EQUITY | Nov 04, 2026, 12:41 PM UTC
M
Zimmer Biomet Reports Q3 Sales, Raises Full-Year Guidance
Zimmer Biomet reported third-quarter net sales of $2.063 billion, up 3.1% reported and 3.7% at constant currency. GAAP diluted EPS fell 13.8% to $1.00, while adjusted diluted EPS was $1.90, unchanged year over year. The
EARNINGS | Nov 04, 2026, 12:33 PM UTC
M
Zimmer Biomet Q3 Net Income $191.6 Million
EARNINGS | Nov 04, 2026, 11:49 AM UTC
L
Zimmer Biomet Reports Third-Quarter Adjusted EPS of $1.90
EARNINGS | Nov 04, 2026, 11:44 AM UTC
M
Zimmer Biomet Provides FY Revenue Growth Outlook
EARNINGS | Nov 04, 2026, 11:43 AM UTC
M
Zimmer Biomet Reports 3Q Sales of $2.06 Billion
EARNINGS | Nov 04, 2026, 11:40 AM UTC
M
Zimmer Biomet Diluted EPS Falls 14% to $1 in Q3 2026
EARNINGS | Nov 04, 2026, 11:40 AM UTC
M
Zimmer Biomet Raises 2026 Adjusted EPS View to $8.50–$8.60
Zimmer Biomet raised its 2026 adjusted EPS view to $8.50–$8.60.
EARNINGS | Nov 04, 2026, 11:33 AM UTC
M
Zimmer Biomet Reports Q3 EPS of USD 1
EARNINGS | Nov 04, 2026, 11:32 AM UTC
M
Zimmer Biomet Reports Third-Quarter Net Income of $191.6M
EARNINGS | Nov 04, 2026, 11:30 AM UTC
M
Zimmer Biomet Announces Dividend of R$ 0.223333333 per Unit
EQUITY | Nov 03, 2026, 08:58 PM UTC
M
Zimmer Biomet Q3 Results Expected November 04
Zimmer Biomet is scheduled to report Q3 results before the market opens on November 04. Revenue is estimated at 2.04 billion USD and EPS at 1.88 USD.
EQUITY | Oct 28, 2026, 11:01 AM UTC
L
Zimmer Biomet and THINK Surgical Extend Exclusive Distribution Agreement
EQUITY | Oct 13, 2026, 11:30 AM UTC
L
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as the Centers for Medicare and Medicaid Services moved to cancel Affordable Care Act coverage for roughl
REGULATION | Sep 23, 2026, 08:42 PM UTC
L
Zimmer Biomet says Kevin Thornal will depart in 2026
Zimmer Biomet said Kevin Thornal, Group President of Global Businesses and the Americas, will depart effective September 30, 2026, with severance benefits under its Restated Executive Severance Plan.
REGULATION | Sep 08, 2026, 08:35 PM UTC
L
Zimmer Biomet promotes multiple Americas leadership roles
Zimmer Biomet says Gary Campbell was promoted to President, Americas; Brian Hatcher to President, Recon, S.E.T., CMFT, Neuro and Biosurgery; and Bradley Kessler to President, Americas — Robotics, Technology and Data.
EQUITY | Sep 08, 2026, 08:30 PM UTC
L
ZBH - Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation
ZBH - Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation
EQUITY | Sep 08, 2026, 08:30 PM UTC
H
Shares of medical device-related companies are trading lower amid possible sympathy with Boston Scientific after that company announced it w
Shares of medical device-related companies are trading lower amid possible sympathy with Boston Scientific after that company announced it was likely to miss its FY26 and Q3 adjusted EPS and net sales growth guidance fol
EARNINGS | Sep 08, 2026, 04:05 PM UTC
L
Zimmer Biomet announces quarterly dividend for Q3 2026
Zimmer Biomet announced a quarterly dividend for the third quarter of 2026.
EQUITY | Aug 28, 2026, 08:15 PM UTC
H
Zimmer Biomet Holdings Raises FY2026 Adj EPS Guidance from $8.40-$8.55 to $8.47-$8.59 vs $8.48 Est; Raises FY2026 Sales Guidance from $8.437
Zimmer Biomet Holdings (NYSE: ZBH ) raises FY2026 Adj EPS guidance from $8.40-$8.55 to $8.47-$8.59 vs $8.48 analyst estimate. Raises FY2026 sales outlook from $8.437 billion-$8.602 billion to $8.553 billion-$8.635 billio
EARNINGS | Aug 05, 2026, 10:32 AM UTC
H
ZBH - Zimmer Biomet Announces Second Quarter 2026 Financial Results
ZBH - Zimmer Biomet Announces Second Quarter 2026 Financial Results
EARNINGS | Aug 05, 2026, 10:30 AM UTC
H
Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled. Top 5 Upgrades: UBS upgraded Intuitive Surgical (I
EARNINGS | Jul 28, 2026, 01:35 PM UTC
L
ZBH assumed Buy W/ $115 PT @ UBS
ZBH assumed Buy W/ $115 PT @ UBS
EQUITY | Jul 28, 2026, 12:42 PM UTC
L
ZBH Initiated Buy at UBS
ZBH Initiated Buy at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
Top Initiations: ATEC BDX BLCO EW SGHT SIBN STE ZBH: BUY @ UBS COO GKOS GMED IART RXST TFX TMDX: NEUTRAL @ UBS INSP STAA: SELL @ UBS BNTC: O
Top Initiations: ATEC BDX BLCO EW SGHT SIBN STE ZBH: BUY @ UBS COO GKOS GMED IART RXST TFX TMDX: NEUTRAL @ UBS INSP STAA: SELL @ UBS BNTC: OUTPERFORM @ Wedbush CRWD: BUY @ Loop FTH: OUTPERFORM @ Opp HRB: EQUAL WEIGHT @ S
EQUITY | Jul 28, 2026, 11:11 AM UTC
L
ZBH u/g Buy @ UBS
ZBH u/g Buy @ UBS
EQUITY | Jul 28, 2026, 09:19 AM UTC
L
BSX DXCM EW GEHC GMED MDT SYK ZBH readthroughs from ABT JNJ ISRG results @ RBC
BSX DXCM EW GEHC GMED MDT SYK ZBH readthroughs from ABT JNJ ISRG results @ RBC
EQUITY | Jul 21, 2026, 12:24 PM UTC
L
Near 200dma resistance SHW ECL ZBH DHI SCI CBOE WH PG RYN PINS PEG VFC AGO BILL WY
Near 200dma resistance SHW ECL ZBH DHI SCI CBOE WH PG RYN PINS PEG VFC AGO BILL WY
EQUITY | Jul 15, 2026, 03:58 PM UTC
H
Other names lower after HCA results, guidance: ISRG -6% BSX -5% ZBH -6% THC -6% UHS -5% CYH -5%
Other names lower after HCA results, guidance: ISRG -6% BSX -5% ZBH -6% THC -6% UHS -5% CYH -5%
EARNINGS | Jul 14, 2026, 03:24 PM UTC
L
Evercore ISI Adjusts Price Target on Zimmer Biomet to $110 From $120
() -- Zimmer Biomet Holdings (ZBH) has an average rating of hold and mean price target of $95.50, according to analysts polled by FactSet. ( covers equity, commodity and economic research from major banks and research fi
EQUITY | Jul 06, 2026, 01:05 PM UTC
L
Reported Earlier: 'Medical device maker Zimmer Biomet to hire 500 in 3 years for tech centre in India'
Reported Earlier: 'Medical device maker Zimmer Biomet to hire 500 in 3 years for tech centre in India' - Reuters
EQUITY | Jul 02, 2026, 11:44 AM UTC
L
Zimmer Biomet shares are trading lower. The company announced it will purchase the iovera cryoeurolysis pain relief device from Pacira BioSc
Zimmer Biomet shares are trading lower. The company announced it will purchase the iovera cryoeurolysis pain relief device from Pacira BioSciences for up to $140 million.
EQUITY | Jun 30, 2026, 02:41 PM UTC